Format

Send to

Choose Destination
See comment in PubMed Commons below
Exp Neurol. 2013 Sep;247:286-8. doi: 10.1016/j.expneurol.2013.01.016. Epub 2013 Jan 23.

Targeting two-pore domain potassium channels - a promising strategy for treating T cell mediated autoimmunity.

Author information

  • 1Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.

Abstract

Two-pore domain potassium channels, such as TASK, are essential players in the regulation of the resting membrane potential. A recent publication in Experimental Neurology revealed that the pharmacological blockade of the two-pore domain potassium channel TASK1 improved clinical disease severity, the number of cellular infiltrates, as well as the degree of demyelination in experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis. This effect was driven by a reduction in the generation of proinflammatory cytokines and proliferation of T lymphocytes. Thus, functional activity of T lymphocytes was identified to be TASK1 dependent suggesting that this class of potassium channels may represent an interesting target for treating T cell-driven autoimmunity directed against the central nervous system.

Copyright © 2013 Elsevier Inc. All rights reserved.

KEYWORDS:

Experimental autoimmune encephalomyelitis; Immunomodulation; Multiple sclerosis; Neuroprotection; Sodium channels

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk